2005
DOI: 10.1593/neo.05520
|View full text |Cite
|
Sign up to set email alerts
|

Combination of Proteasomal Inhibitors Lactacystin and MG132 Induced Synergistic Apoptosis in Prostate Cancer Cells

Abstract: The proteasome inhibitor Velcade (bortezomib/PS-341) has been shown to block the targeted proteolytic degradation of short-lived proteins that are involved in cell maintenance, growth, division, and death, advocating the use of proteasomal inhibitors as therapeutic agents. Although many studies focused on the use of one proteasomal inhibitor for therapy, we hypothesized that the combination of proteasome inhibitors Lactacystin (AG Scientific, Inc., San Diego CA) and MG132 (Biomol International, Plymouth Meetin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
28
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 35 publications
(31 citation statements)
references
References 50 publications
3
28
0
Order By: Relevance
“…TRAIL is an effective apoptotic agent by itself or in combination with other apoptotic drugs. We have shown synergistic increase in apoptotic response when TRAIL was combined with antiprogestin mifepristone (43) or by inhibiting the function of heat shock protein 90 (27,34), inhibiting the proteasomal activity (34), or treatment with histone deacetylase inhibitor, SAHA (25). Our present results show that treatment with both TRAIL and CGP Figure 3.…”
Section: Discussionmentioning
confidence: 50%
See 1 more Smart Citation
“…TRAIL is an effective apoptotic agent by itself or in combination with other apoptotic drugs. We have shown synergistic increase in apoptotic response when TRAIL was combined with antiprogestin mifepristone (43) or by inhibiting the function of heat shock protein 90 (27,34), inhibiting the proteasomal activity (34), or treatment with histone deacetylase inhibitor, SAHA (25). Our present results show that treatment with both TRAIL and CGP Figure 3.…”
Section: Discussionmentioning
confidence: 50%
“…This assay is highly sensitive and is specific to cell death due to apoptosis but does not measure necrotic cells. Apoptosense kit has been used successfully in measuring apoptosis in prostate cancer cells (25,27,34). On completion of the experiments, cells were harvested and total protein was extracted as described below.…”
Section: Introductionmentioning
confidence: 99%
“…Lactacystin Increases sf-CD Accumulation in AtT-20 CellsIn AtT-20 cells expressing Myc-TMD-CD or PAM-1, sf-CD is barely detectable in the absence of the proteasomal inhibitor MG132, a peptidyl aldehyde that also inhibits calpain 1 (15,29). Because the proteasome seemed to play a key role in sf-CD metabolism, we tested another inhibitor.…”
Section: Sf-cd Production From Myc-tmd-cd Ismentioning
confidence: 99%
“…Because the proteasome seemed to play a key role in sf-CD metabolism, we tested another inhibitor. We chose lactacystin, a ␤-lactone that binds covalently but also inhibits cathepsins A and B (29,30). We first examined AtT-20 cells expressing Myc-TMD-CD and treated them for 5 h with lactacystin or MG132 (Fig.…”
Section: Sf-cd Production From Myc-tmd-cd Ismentioning
confidence: 99%
“…Apoptosense is highly sensitive and is specific to apoptosis. Apoptosense kit has been utilized successfully in our (14,21,22), and other laboratories (23)(24)(25). Protein extract was added to 96-well plates pre-coated with mouse monoclonal M30 antibody, horseradish peroxidase tracer solution was added to the wells and incubated for 4 h. Color was developed by adding tetramethyl benzidine solution and the optical density was measured at 450 nm on a Spectra MAX340 microplate reader (Molecular Devices Corp., Sunnyvale, CA).…”
Section: Measurement Of Apoptosismentioning
confidence: 99%